US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Neovacs (0W8U) 銘柄情報

Neovacs (0W8U)

0.363

0.00

( 0.00% )

更新日時： 09:00:00

Neovacs (0W8U) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.363

( - )

買値

0.363

売値

0.363

出来高

0.00

平均取引量 (3 か月)

4,606 €

財務取引量

-

0.00 日の範囲 0.00

0.363 52 週間の範囲 363.00

時価総額

企業価値

335.753k

前日終値

0.363

始値

-

時刻

最終取引時間

-

VWAP

-

歳入

199.27k

純利益

-4.36M

発行済株式数

159,064

浮動株比率 (%)

-

機関投資家保有比率 (%)

-

配当利回り

PER

-

株価売上高倍率 (PSR)

1.02

1 株当たり利益 (EPS)

-

ベータ

-1.22k

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company’s product pipeline includes Kinoid,... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company’s product pipeline includes Kinoid, a therapeutic vaccine which allows the immune system to generate natural polyclonal antibodies. IFNa Kinoid, an anti-interferon alpha vaccine which completed Phase I / IIa and IIb clinical trial for the treatment of lupus erythematosus; and Phase IIa clinical trial for the treatment of asthma, dermatomyositis, and all food allergies; and kinoid vaccine that simultaneously targets IL-4 and IL-13 allergies. The company was founded in 1993 and is based in Suresnes, France. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.neovacs.com

本社

Suresnes, France

設立

1993

Neovacs is listed in the sector of the ロンドン証券取引所 with ticker 0W8U. The last closing price for Neovacs was 0.36 €. Over the last year, Neovacs shares have traded in a share price range of 0.363 € to 363.00 €.

Neovacs currently has 159,064 shares in issue. The market capitalisation of Neovacs is 57,740.23 € .

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	-362.637	-99.9	363	363	363	0	0	DE
52	0	0	0.363	363	0.363	20217	0.363	DE
156	-2903.637	-99.9875	2904	29040000	0.363	47424	873637.88483	DE
260	0	0	0.363	29040000	0.363	37886	630811.926681	DE

0W8U - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?

The current share price of Neovacs is 0.363 €

How many Neovacs shares are in issue?

Neovacs has 159,064 shares in issue

What is the market cap of Neovacs?

The market capitalisation of Neovacs is EUR 57.74k

What is the 1 year trading range for Neovacs share price?

Neovacs has traded in the range of 0.363 € to 363.00 € during the past year

What is the cash to sales ratio of Neovacs?

The cash to sales ratio of Neovacs is 1.02

What is the registered address of Neovacs?

The registered address for Neovacs is 14 Rue de la Republic FR, Suresnes, Ile-de-France, 92150

What is the Neovacs website address?

The website address for Neovacs is www.neovacs.com

glenn1919

glenn1919 5分前

JLHL...................................https://stockcharts.com/sc3/ui/?s=JLHL&p=w&b=5&g=0&id=p86431144783

abew4me

abew4me 5分前

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

- Pivotal Phase 3 trial enrolls 850 patients, exceeding original projections
- Study completion on track: symptomatic data readout - Q1 2027, disease-modifying data readout - Q1

tdbowieknife

tdbowieknife 5分前

No they don't... AMFN does not have such a device. There is no evidence in filings, patents, or technical literature of a “magnetic wave modulator interface.”
It’s a marketing phrase designed to sound technical while avoiding proof.

.

.

W

ducci1

Scalp/Out 745P .83! Take It! 3 Bagger! Tks Boys! Reenter !

layton

PSRU Security Details
Share Structure
Market Cap Market Cap
2,146,027
07/06/2026
Authorized Shares
22,000,000,000
07/06/2026
Outstanding Shares
21,460,268,251
07/06/2026
Restricted
940,101,702
07/06/2026

Truthsocial

Truthsocial 7分前

Not going to be a reverse with all the catalysts upcoming in near future.....

Stop
Look
Listen

I hear a train a coming .....get on or get off imo

Let's go ISOPET now and RDGL now

WooptdooU

WooptdooU 7分前

Imo, if the grifter, flat faced critter leaves, so does the cob, the wealth manager level Grifter. This GRIFTER GIFTED his GRIFT and SEEMS TO SOME to have skirted insider selling rules. Pig-like!

LOVELWLG

LOVELWLG 8分前

I guess like Lebby Ives doesn't follow the stock price either.🤣🤣🤣

Monk4444

Monk4444 8分前

Maybe Gupta's in bed with Nissen.

Golden Cross

Golden Cross 8分前

May start buying below 40K

Red_Right_Hand

Red_Right_Hand 8分前

Push back. Give it slide 18 and ask again. Or just look at slide 18 yourself and come to your own conclusion. Nobody is saying he gave up his doctoring job at Lifetime/Brown U, just that he's working for NWBO.

bobby1151

bobby1151 8分前

Hey band aid please post DETAIL'S of "THIS FLOP" -I do not C a flop!!!!!?????

CatfishHunter

CatfishHunter 8分前

You remind me of the bully in school who never got picked for a dodgeball team at recess so instead he would rather just bully and make fun of everybody from the sidelines. In my opinion! You don’t own shares you’re just bitter and a troll.

DimesForShares

DimesForShares 9分前

Thompson really knows how to kill momentum.
Well done, Sir. Well done.
Watch those recent gains turn red…
The KBLB way.

Jon Jon

Jon Jon 9分前

All you need is a magnetic wave modulator interface and presto change-o you have your fast-pulsed torsatron. Do they really have that...hmmmmm.

ducci1

Scalp 1/2 745P .85! Take It! 3 Bagger!

SSKILLZ1

SSKILLZ1 9分前

Savvy Pick 10 Contest #3 Deadline on Friday Before Market Close.

Remember to get your picks in before Friday's Market Close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-3-50749

SSKILLZ1

SSKILLZ1 10分前

Savvy Pick 10 Contest #3 Deadline on Friday Before Market Close.

Remember to get your picks in before Friday's Market Close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-3-50749

flipper44

flipper44 10分前

“….(and as quietly as possible....)” — RRR

EpicSage

EpicSage 10分前

$BCTX today announced that it has engaged Charles River Associates (CRA) (Nasdaq: $CRAI) and Kaleio, Inc. to support commercial strategy, market access evaluation and brand planning for Bria-IMT.

NEWS: https://bit.ly/3QK1eTD

PutzMueler

PutzMueler 10分前

What Gov momentum? and what has Gov momentum done for us?

Is everybody blind?

JEEZUS

tdbowieknife

tdbowieknife 10分前

Hey Nelson/Hawkins... When are you going to start approving the answers??? Come on... Let's get on the ball here! Start proving you all are telling the "truth"...

.

.

Watch your wallet

Buyer Beware
Social M

Rainer

Rainer 10分前

BELR - https://www.otcmarkets.com/stock/BELR/news/Bell-Rose-Capital-Inc-OTCID-BELR-Asserts-PublicCompany-Leadership-as-4biddenknowledge-Ecosystem-Enters-Scaled-Expansion-?id=527440

Lonewolf1

Lonewolf1 11分前

MU now 38% off the recent highs.
Oh my.....

WorstLuck

WorstLuck 11分前

RVMD

https://ir.revmed.com/news-releases/news-release-details/european-medicines-agency-expedites-assessment-revolution

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
July 7, 2026
PDF Versio

Aisera Share Cls Lvl Pre...

UCITS ETF ACC Ireland (ID)

Morgan Stanley Finance L...

Spearmint Resources

FORJA TAURUS PN

Link Reservations (EM)

West Red Lake Gold Mines

Anadarko Petroleum

Tri City Bankshares (ID)

ETFlab Investment

IBC Advanced Alloys (QB)

Sunwise Essential 2 Ci P...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。